Splinting for Dupuytren's Contracture Release

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00575458
Recruitment Status : Completed
First Posted : December 18, 2007
Last Update Posted : November 16, 2010
Information provided by:
Massachusetts General Hospital

Brief Summary:
This study is comparing two different kinds of splints for patients who have had a surgical contracture release of dupuytren's disease. It compares a static splint and a dynamic splint.

Condition or disease
Dupuytren's Disease

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Randomized Comparison of Dynamic Versus Static Splinting After Dupuytren's Contracture Release
Study Start Date : June 2005
Primary Completion Date : June 2010
Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Static Splint
Dynamic Splint

Primary Outcome Measures :
  1. DASH questionnaire, PCS questionnaire, Wahler Physical Symptom Inventory, CESD questionnaire [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Orthopaedic Hand Clinic

Inclusion Criteria:

  • 18 years or older
  • males and females with Dupuytren's contracture
  • patients with contracture of less than 30 degrees of MCP contractions and no contractions of the IP joints

Exclusion Criteria:

  • previous surgical treatment for Dupuytren's
  • contracture of MCP greater than 30 degrees
  • contraindications for dynamic splinting (upper limb amputees, paresis, ect.)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00575458

United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Massachusetts General Hospital
Principal Investigator: David C. Ring, MD Massachusetts General Hospital

Responsible Party: David Ring, Massachusetts General Hospital Identifier: NCT00575458     History of Changes
Other Study ID Numbers: 2005p002466
First Posted: December 18, 2007    Key Record Dates
Last Update Posted: November 16, 2010
Last Verified: November 2010

Additional relevant MeSH terms:
Dupuytren Contracture
Joint Diseases
Musculoskeletal Diseases
Muscular Diseases
Neoplasms, Fibrous Tissue
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Connective Tissue Diseases